Foyda yangilanishi: Merck, PepsiCo va Eaton to‘rtinchi chorak natijalarini e’lon qildi

Reuters 8 October – On Thursday, reports emerged that the AI company Firmus backed by NVIDIA (NVDA.O) is considering adjusting the terms of its widely anticipated $5 billion IPO, causing Maas Group (MGH.AX) shares in Australia to plunge by up to 30%. The price dropped to 4.47 AUD, marking the biggest daily loss and the lowest point since May 6, evaporating approximately 694 million AUD (483.37 million USD) in market value for the construction services company. Here are additional details: Maas holds a 3.2% stake in the data center operator; earlier in August, it pledged an extra investment of 300 million AUD through common and preferred shares priced at 230 AUD per share. In a statement to the exchange, Maas noted that speculation over whether the IPO will proceed as planned has put pressure on market sentiment, and added that it has no undisclosed information explaining the current trading situation. Firmus lists OpenAI as an anchor client and is preparing the second-largest IPO in Australian history. Earlier this week, reports indicated the company may reduce its offering price from 11 AUD per share. If this IPO succeeds, it will be the largest in Australia in almost thirty years, second only to the Telstra IPO in 1997 (TLS.AX), which was approximately $10 billion. Before Thursday’s sharp drop, Maas Group shares had climbed about 44% in the past 12 months, as investors valued its connection to AI-driven data center construction. Firmus has not responded immediately to Reuters’ request for comment. (1 USD = 1.4358 AUD) For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automated translation may contain errors or lack context, Reuters does not guarantee the accuracy of automated translation and provides it only for readers' convenience. Reuters bears no responsibility for any loss or damage arising from the use of automated translation.

Ma’lumotlarga ko‘ra, SK Hynix (SKHY.US) kompaniyasining flash xotira bo‘limi Solidigm kelgusi yilda AQShda IPO o‘tkazishni rejalashtirmoqda va bosh bank sifatida Goldman Sachs hamda Morgan Stanley tanlandi.

Pfizer (PFE.US) chorshanba kuni e’lon qildi, AQSh Oziq-ovqat va dori-darmon ma’muriyati (FDA) uning tirozin kinaza inhibitörü Tukysa (tucatinib)ni muayyan ko’krak bezi saratoni uchun birinchi bosqich terapiya sifatida birgalikdagi davolash rejasi doirasida tasdiqlaganini.